Search Results
Mar 05, 2026, 07:00 ET CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
blood pumps already in the hospital (e.g. dialysis, continuous renal replacement therapy or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body, through our cartridges where toxic substances are removed, and then back into the
More news about: Cytosorbents Corp
Mar 05, 2026, 07:00 ET Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering,
More news about: Insmed Incorporated
Mar 05, 2026, 03:03 ET Sectra acquires Oxipit, advancing autonomous AI capabilities in diagnostic imaging
https://news.cision.com/sectra/i/radiologist-reading-lung-x-ray-in-sectra-s-solution,c3516585Radiologist reading lung X-ray in Sectra's solution
More news about: Sectra
Mar 04, 2026, 17:31 ET Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight
said it had been granted orphan drug status by the European Medicines Agency for LTI-03, its leading investigational therapy designed to help maintain lung function in people with idiopathic pulmonary fibrosis.What are Orphan Drugs?Orphan drugs are medicines developed to diagnose,
More news about: DelveInsight Business Research, LLP
Mar 04, 2026, 10:00 ET Airiver Medical Granted FDA's Breakthrough Device Designation for Pulmonary Drug Coated Balloon to Treat Central Airway Stenosis; First Patient Treated in Clinical Trial
trial."Central airway stenosis, otherwise defined as airway narrowing, is often associated with prolonged intubation, tracheostomy, stenting, tuberculosis or lung transplant. There are approximately 100,000 tracheo-bronchial stenting and dilation procedures performed annually in the United States.The Airiver
More news about: Airiver Medical
Mar 04, 2026, 09:00 ET Lunit to Be Featured in 21 AI Imaging Studies on Breast Cancer and Lung Disease at ECR 2026
Repeated evaluation of AI for lung nodule detection in chest radiographs: version-to-version evaluation in a multicentre study
More news about: Lunit
Mar 04, 2026, 07:18 ET Brayton Purcell LLP Highlights New National InvestigateTV Report Exposing the Severe Health Consequences of Crystalline Silica Artificial Stone
crisis faced by California countertop fabrication worker Rodolfo Figueroa, whose decades of cutting artificial stone resulted in catastrophic lung damage.
More news about: Brayton Purcell LLP
Mar 04, 2026, 07:05 ET Allegheny Health Network's Cardiovascular Institute Achieves Elite National Ratings for Cardiac Surgery Excellence
surgeons, researchers, and allied healthcare professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as other surgical procedures within the chest. The Society's mission is to enhance the ability of cardiothoracic surgeons to
More news about: Allegheny Health Network
Mar 03, 2026, 17:00 ET Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases
https://www.antengene.com/newsinfo/442 For more information, please contact:Investor Contacts: Donald LungE-mail: [email protected] BD Contacts:Ariel
More news about: Antengene Corporation Limited
Mar 03, 2026, 17:00 ET Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases
https://www.antengene.com/newsinfo/442 For more information, please contact:Investor Contacts: Donald LungE-mail: [email protected] BD Contacts:Ariel
More news about: Antengene Corporation Limited
Mar 03, 2026, 16:01 ET Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
that over 229,000 adults in the U.S. will be diagnosed with lung cancer in 2026. Lung cancer is the leading cause of cancer death in the U.S., with non-small cell lung cancer (NSCLC) being the most common type accounting for 77% of all lung cancer diagnoses.2 RET fusions are implicated in
More news about: Rigel Pharmaceuticals, Inc.
Mar 03, 2026, 12:19 ET Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes
provider worldwide, combining Gleamer's BoneView and ChestView FDA-cleared algorithms with DeepHealth's existing suite of mammography, lung, and prostate AI solutions."As imaging volumes continue to rise amid an accelerating shortage of radiologists worldwide, reengineering high-volume
More news about: USA News Group
Mar 03, 2026, 10:44 ET AI Analysis of Eye Photos May Help Detect Serious Lung and Heart Conditions in Premature Infants
Researchers developed an artificial intelligence (AI) model that can analyze routine eye images of premature infants to detect risk for serious lung and heart diseasesThe study evaluated 493 premature infants across seven neonatal intensive care units (NICUs)AI predicted risk of
More news about: University of Colorado Anschutz
Mar 03, 2026, 10:00 ET The Mark Foundation Announces $4M in 2026 Drug Discovery Awards
DegradationEric Fischer, PhD, and Scott Armstrong, MD, PhD, Dana-Farber Cancer InstituteTargeting the proteins fueling leukemia and lung cancer to develop a more effective way to treat cancers driven by faulty gene expression.For more information on the Drug Discovery Award program
More news about: The Mark Foundation for Cancer Research
Mar 03, 2026, 09:00 ET Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
results showing substantial event-free survival benefit for Retevmo (selpercatinib) as an adjuvant therapy in early-stage RET fusion-positive lung cancer, expanding the role of targeted therapy in oncology. The LIBRETTO-432 trial enrolled 151 patients across a global, multicenter study, generating
More news about: USA News Group
Mar 03, 2026, 08:10 ET Journal of Analytical Toxicology Publishes Peer‑Reviewed Validation Study Demonstrating Accuracy of Omega Laboratories' Test Method for Detecting Marijuana in Breath Samples Using Cannabix Technologies' Breath Collection Unit
BCU as a stable, consistent and portable tool for breath collection. The BCU offers a quick, non-invasive collection method regardless of subject's lung function.The BCU adds several safeguards to the reproducible collection process, including the monitoring of subject's breath pressure and
More news about: Omega Laboratories, Inc.
Mar 03, 2026, 07:59 ET Pierre Fabre Pharmaceuticals Submits Type A Meeting Request to U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA)
therapies in development for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), NRAS-mutant melanoma, non-small cell lung cancer with mutation or amplification of MET, and X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED). Pierre Fabre Pharmaceuticals is headquartered
More news about: Pierre Fabre Pharmaceuticals
Mar 03, 2026, 07:00 ET SpliSense Granted EMA EARLY PRIME Designation for SPL84 in Cystic Fibrosis
cohorts demonstrated a favorable safety profile, with no treatment-related serious adverse events observed, and a clinically significant improvement in lung function (ppFEV1) in up to 70% of SPL84-treated participants. The estimated mean absolute change in ppFEV1 compared with placebo was 10. These data
More news about: Splisense
Mar 02, 2026, 19:10 ET VARON Recommends Winter Respiratory Care as Germany Faces Seasonal Health Challenges
respiratory wellness during winter:Maintain balanced indoor humidity to help protect airway moistureStay hydrated to support lung and respiratory system functionPerform light indoor exercises to promote circulationMonitor breathing comfort during sleep and rest
More news about: Varon oxygen concentrator
Mar 02, 2026, 18:30 ET SK Telecom Expands Global AI Partnerships at MWC Barcelona 2026
Technology Groups On the same day, CEO Jung also met with e& Group CEO Hatem Dowidar and Group Chief Strategy Officer (GCSO) Harrison Lung to further strengthen their strategic partnerships in expanding global AI infrastructure.On March 3, CEO Jung is scheduled to meet with CEO Christel
More news about: SK Telecom
Mar 02, 2026, 16:16 ET Pritzker Hageman Files Legionnaires' Disease Lawsuit Against Las Vegas Casino Hotels After Guest's Death
Symptoms may include cough, shortness of breath, fever, headache, and muscle aches. People over 50, current or former smokers, and those with chronic lung disease or weakened immune systems are at increased risk of severe illness. "Legionnaires' disease is easily preventable when properties implement
More news about: Pritzker Hageman, P.A.
Mar 02, 2026, 16:05 ET Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
event.About ROS1+ NSCLCEach year, more than one million people globally are diagnosed with non-small cell lung cancer (NSCLC), the most common form of lung cancer. It is estimated that approximately 2% of patients with NSCLC have ROS1+ disease. About 35% of patients newly diagnosed
More news about: Nuvation Bio Inc.
Mar 02, 2026, 16:05 ET Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results
in non-small cell lung cancer (NSCLC), 4/4 (100%) in endometrial cancer, and 1/2 (50%) in urothelial cancer.There were low rates of adverse events attributed to unconjugated payload such as hematological toxicities and diarrhea, and there were no cases of interstitial lung disease, showing a
More news about: Biohaven Ltd.
Mar 02, 2026, 09:10 ET Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress
breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms
More news about: Anixa Biosciences, Inc.
Mar 02, 2026, 08:30 ET IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas
liquid nitrogen to create large lethal zones for maximum efficacy in tumor destruction in benign and cancerous lesions, including in the breast, kidney, lung, and liver.ProSense® enhances patient and provider value by accelerating recovery, reducing pain, surgical risks, and complications. With its
More news about: IceCure Medical